How to Help Your Patients Find Lomustine In Stock: A Provider's Guide

When you prescribe lomustine, your work doesn't end with writing the prescription. Many patients will struggle to fill it — due to limited pharmacy availability, high cost, and lack of Medicare or Medicaid coverage. This guide gives your oncology care team a proactive, systematic approach to ensuring patients receive their lomustine dose on time.

Why Patients Struggle to Fill Lomustine Prescriptions

Lomustine is a specialty hazardous chemotherapy dispensed one dose per 6-week cycle. This creates a unique dispensing environment:

Most retail pharmacies (CVS, Walgreens, Rite Aid) don't maintain lomustine inventory

Not covered by Medicare Part D or Medicaid since 2021 — patients may face $600–$2,950 per dose out-of-pocket

Prior authorization required by most private insurers, often causing delays

Patients receiving lomustine are often immunocompromised and may not have the energy or capacity to navigate these barriers alone

Recommended Provider Workflow

Step 1: Initiate the Prescription at Least 2 Weeks Before Cycle Date

The 6-week fixed dosing schedule of lomustine is non-negotiable from a safety standpoint — don't administer more frequently. But it also means you know exactly when the next dose is due. Build a protocol that initiates the prescription and pharmacy routing process at least 2 weeks before each cycle date to allow time for:

Insurance prior authorization (typically 3–7 business days if approved on first submission)

Pharmacy procurement and ordering if not in stock

Patient assistance program enrollment if needed

Step 2: Route to Your Cancer Center's Specialty Pharmacy

If your institution has an in-house pharmacy or an affiliated specialty pharmacy, this is the most reliable channel for lomustine. These pharmacies maintain hazardous drug dispensing capabilities and typically have established supplier relationships.

For patients who prefer a community pharmacy or need mail delivery, national specialty pharmacy networks to consider include: Accredo (Express Scripts), CVS Specialty, Walgreens Specialty Pharmacy, and BioPlus Specialty Pharmacy.

Step 3: Screen for Insurance Coverage Early

At the time of prescribing, have your financial counselor or care coordinator run a benefits investigation. Key questions:

Does the patient's commercial plan cover lomustine/Gleostine under the pharmacy or medical benefit?

What tier is it, and what is the estimated copay?

Is prior authorization required? What clinical documentation will be needed?

For Medicare patients: Is the patient enrolled in a Medicare Advantage plan that may have separate pharmacy coverage?

Step 4: Connect Uninsured or Underinsured Patients to Assistance Programs

For patients without adequate coverage, have your social worker or patient navigator help enroll in:

Prescription Hope: Works with any insurance status; approximately $70/month for lomustine

HealthWell Foundation / PAN Foundation: Disease-specific funds may be available for brain tumor or lymphoma patients

National Brain Tumor Society / Leukemia & Lymphoma Society: May have financial assistance or guidance resources

Step 5: Use medfinder to Rapidly Locate Available Pharmacies

When a patient calls your office unable to find lomustine at their local pharmacy, your care team can use medfinder to quickly identify which pharmacies in the patient's area have it in stock. medfinder calls pharmacies on the patient's behalf and reports results via text — reducing the time your staff spends on the phone and ensuring faster access to medication.

Documentation Checklist for Each Lomustine Prescription

Confirm CBC nadir from previous cycle recovered (platelets >100K, WBC >4K)

Document dose calculation based on current BSA and prior nadir

Confirm pharmacy has received prescription and can fill within the required timeframe

Verify insurance coverage or patient assistance program enrollment

Document patient education on safe handling (gloves, do not crush capsules) and what to report (fever, unusual bleeding, signs of infection)

For the broader clinical picture on lomustine supply and alternatives, see our lomustine shortage guide for providers.